Profit & Loss

ABL BIOTECHNOLOGIES LTD.

NSE : NABSE : 526955ISIN CODE : INE707D01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.810 (0 %)
PREV CLOSE ( ) 0.81
OPEN PRICE ( ) 0.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 37663
TODAY'S LOW / HIGH ( )0.75 0.81
52 WK LOW / HIGH ( ) 0.750.81
NSE
This Company is not listed in NSE
Select year
( in Million)
Particulars
Mar 2012
Mar 2011
INCOME :
  
  
Gross Sales
0.42
     Sales
0.42
     Job Work/ Contract Receipts
     Processing Charges / Service Income
     Revenue from property development
     Other Operational Income
0.00
0.00
Less: Excise Duty
Net Sales
0.42
EXPENDITURE :
Increase/Decrease in Stock
Raw Material Consumed
0.71
     Opening Raw Materials
0.71
     Purchases Raw Materials
     Closing Raw Materials
     Other Direct Purchases / Brought in cost
     Other raw material cost
0.00
0.00
Power & Fuel Cost
0.02
     Electricity & Power
0.02
     Oil, Fuel & Natural gas
0.00
0.00
     Coals etc
0.00
0.00
     Other power & fuel
0.00
0.00
Employee Cost
0.15
1.27
     Salaries, Wages & Bonus
0.15
1.25
     Contributions to EPF & Pension Funds
     Workmen and Staff Welfare Expenses
0.02
     Other Employees Cost
0.00
0.00
Other Manufacturing Expenses
0.04
     Sub-contracted / Out sourced services
     Processing Charges
     Repairs and Maintenance
     Packing Material Consumed
     Other Mfg Exp
0.00
0.04
General and Administration Expenses
0.52
2.56
     Rent , Rates & Taxes
0.48
0.84
     Insurance
     Printing and stationery
0.01
     Professional and legal fees
0.36
     Traveling and conveyance
0.29
     Other Administration
0.04
1.06
Selling and Distribution Expenses
     Advertisement & Sales Promotion
     Sales Commissions & Incentives
     Freight and Forwarding
     Handling and Clearing Charges
0.00
0.00
     Other Selling Expenses
0.00
0.00
Miscellaneous Expenses
0.49
1.13
     Bad debts /advances written off
     Provision for doubtful debts
     Losson disposal of fixed assets(net)
     Losson foreign exchange fluctuations
     Losson sale of non-trade current investments
     Other Miscellaneous Expenses
0.49
1.13
Less: Expenses Capitalised
Total Expenditure
1.16
5.74
Operating Profit (Excl OI)
-1.16
-5.32
Other Income
0.07
0.04
     Interest Received
     Dividend Received
     Profit on sale of Fixed Assets
     Profits on sale of Investments
     Provision Written Back
     Foreign Exchange Gains
     Others
0.07
0.04
Operating Profit
-1.10
-5.28
Interest
0.02
0.01
     InterestonDebenture / Bonds
     Interest on Term Loan
     Intereston Fixed deposits
     Bank Charges etc
0.02
0.01
     Other Interest
0.00
0.00
PBDT
-1.11
-5.29
Depreciation
0.68
0.70
Profit Before Taxation & Exceptional Items
-1.79
-5.99
Exceptional Income / Expenses
Profit Before Tax
-1.79
-5.99
Provision for Tax
     Current Income Tax
     Deferred Tax
     Other taxes
0.00
0.00
Profit After Tax
-1.79
-5.99
Extra items
0.00
0.00
Minority Interest
Share of Associate
Other Consolidated Items
Consolidated Net Profit
-1.79
-5.99
Adjustments to PAT
Profit Balance B/F
-178.50
-172.51
Appropriations
-180.29
-178.50
     General Reserves
     Proposed Equity Dividend
     Corporate dividend tax
     Other Appropriation
Equity Dividend %
Earnings Per Share
-0.22
-0.73
Adjusted EPS
-0.22
-0.73

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.